IL6 and cancer: These findings are in line with previous reports showing that the circulating level of IL-6 correlates with weight loss in cancer patients, as this cytokine can act alone as a driver of systemic inflammation in cancer cachexia, inducing anorexia, body mass loss, and an acute-phase protein response [57,58,59,60,61].